Back

IBB Stock

Live symbol workspace

IBB market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $169.37
Trend Flat
Sentiment Neutral

Price Chart

📈
Loading chart for IBB...
Powered by TradingView
{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support
$160.90
Resistance
$177.84

Volume & Momentum

Volume
Weak
0.8x avg
Momentum
0%
Weak

Technical Context

Current price
$169.37
RSI context
50

Market Sentiment

50
Neutral

Stock Metrics

Daily Vol
0%
VIX Est
20
Weekly
0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%
— 0.0 pts vs previous week
Avg confidence across 7 calls in the last 7 days

What sources say

No news-sourced AI calls in the last 30 days.

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

IBB News Intelligence (6 articles)

AI-curated news influencing IBB price, sentiment, and trend

Explore All IBB News with AI Analysis
Economy
2 hours, 32 minutes ago

IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?

Established pharmaceutical giants have delivered lower volatility and higher income than clinical-stage biotech exposure over the past five years.

Impact on IBB: May pressure downward momentum
Financial market analysis indicating bearish sentiment based on current trends. Medium (60%)
View full analysis →
Yahoo Finance 60% confidence
Economy
1 month, 1 week ago

Why Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks

Bristol Myers Squibb has an attractive 4.4% yield, and its 16x P/E is below the pharma average of 24x.

Impact on IBB: Neutral market sentiment indicated
Analysis of stock market developments showing neutral sentiment. Medium (50%)
View full analysis →
Yahoo Finance 50% confidence
Economy
3 months, 2 weeks ago

Should You Buy Bristol Myers Squibb Stock for Its 4.4%-Yielding Dividend?

The healthcare company has been a top dividend growth stock for years.

Impact on IBB: Neutral market sentiment indicated
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. High (94%)
View full analysis →
Yahoo Finance 94% confidence
Economy
3 months, 2 weeks ago

DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing

iShares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names. That structure …

Impact on IBB: The reduction in IBB holdings by DFNA Capital may lead to a …
DAFNA Capital reduced its holdings in the iShares Biotechnology ETF (IBB) as part of its … Medium (50%)
View full analysis →
Yahoo Finance 50% confidence
Economy
5 months ago

Why Bristol Myers Squibb Stock Topped the Market Today

At the end of last year, the company did particularly well with its lineup of newer medications.

Impact on IBB: Market impact analysis based on bullish sentiment with 90% confidence.
Bristol Myers Squibb stock outperformed the market due to its strong performance with newer medications … High (90%)
View full analysis →
Yahoo Finance 90% confidence
🤖

AI Analysis

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
0%
AI Model Multi-Provider AI Analysis
Open article